Literature DB >> 28053029

Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.

Efrat Lasser-Katz1, Alon Simchovitz2, Wei-Hua Chiu1, Wolfgang H Oertel3, Ronit Sharon4, Hermona Soreq2, Jochen Roeper5, Joshua A Goldberg6.   

Abstract

α-Synuclein overexpression (ASOX) drives the formation of toxic aggregates in neurons vulnerable in Parkinson's disease (PD), including dopaminergic neurons of the substantia nigra (SN) and cholinergic neurons of the dorsal motor nucleus of the vagus (DMV). Just as these populations differ in when they exhibit α-synucleinopathies during PD pathogenesis, they could also differ in their physiological responses to ASOX. An ASOX-mediated hyperactivity of SN dopamine neurons, which was caused by oxidative dysfunction of Kv4.3 potassium channels, was recently identified in transgenic (A53T-SNCA) mice overexpressing mutated human α-synuclein. Noting that DMV neurons display extensive α-synucleinopathies earlier than SN dopamine neurons while exhibiting milder cell loss in PD, we aimed to define the electrophysiological properties of DMV neurons in A53T-SNCA mice. We found that DMV neurons maintain normal firing rates in response to ASOX. Moreover, Kv4.3 channels in DMV neurons exhibit no oxidative dysfunction in the A53T-SNCA mice, which could only be recapitulated in wild-type mice by glutathione dialysis. Two-photon imaging of redox-sensitive GFP corroborated the finding that mitochondrial oxidative stress was diminished in DMV neurons in the A53T-SNCA mice. This reduction in oxidative stress resulted from a transcriptional downregulation of voltage-activated (Cav) calcium channels in DMV neurons, which led to a reduction in activity-dependent calcium influx via Cav channels. Thus, ASOX induces a homeostatic remodeling with improved redox signaling in DMV neurons, which could explain the differential vulnerability of SN dopamine and DMV neurons in PD and could promote neuroprotective strategies that emulate endogenous homeostatic responses to ASOX (e.g., stressless pacemaking) in DMV neurons. SIGNIFICANCE STATEMENT: Overexpression of mutant α-synuclein causes Parkinson's disease, presumably by driving neurodegeneration in vulnerable neuronal target populations. However, the extent of α-synuclein pathology (e.g., Lewy bodies) is not directly related to the degree of neurodegeneration across various vulnerable neuronal populations. Here, we show that, in contrast to dopamine neurons in the substantia nigra, vagal motoneurons do not enhance their excitability and oxidative load in response to chronic mutant α-synuclein overexpression. Rather, by downregulating their voltage-activated calcium channels, vagal motoneurons acquire a stressless form of pacemaking that diminishes mitochondrial and cytosolic oxidative stress. Emulating this endogenous adaptive response to α-synuclein overexpression could lead to novel strategies to protect dopamine neurons and perhaps delay the onset of Parkinson's disease.
Copyright © 2017 the authors 0270-6474/17/370048-11$15.00/0.

Entities:  

Keywords:  Lewy pathology; acetylcholine; homeostasis; multiphoton microscopy; neurodegeneration; oxidative stress

Mesh:

Substances:

Year:  2017        PMID: 28053029      PMCID: PMC6705667          DOI: 10.1523/JNEUROSCI.1079-16.2016

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  13 in total

Review 1.  Na+ leak-current channel (NALCN) at the junction of motor and neuropsychiatric symptoms in Parkinson's disease.

Authors:  Merve Kasap; Donard S Dwyer
Journal:  J Neural Transm (Vienna)       Date:  2021-05-07       Impact factor: 3.575

Review 2.  Neurophysiology of the brain stem in Parkinson's disease.

Authors:  Cecilia Bove; R Alberto Travagli
Journal:  J Neurophysiol       Date:  2019-03-27       Impact factor: 2.714

3.  Characterization of the Basic Membrane Properties of Neurons of the Rat Dorsal Motor Nucleus of the Vagus in Paraquat-Induced Models of Parkinsonism.

Authors:  C Bove; F H Coleman; R A Travagli
Journal:  Neuroscience       Date:  2019-09-03       Impact factor: 3.590

4.  Role of upregulation of the KATP channel subunit SUR1 in dopaminergic neuron degeneration in Parkinson's disease.

Authors:  Min Liu; Cui Liu; Xue Xiao; Shuai-Shuai Han; Ming-Xia Bi; Qian Jiao; Xi Chen; Chun-Ling Yan; Xi-Xun Du; Hong Jiang
Journal:  Aging Cell       Date:  2022-04-20       Impact factor: 11.005

5.  Cholinergic Interneurons Amplify Corticostriatal Synaptic Responses in the Q175 Model of Huntington's Disease.

Authors:  Asami Tanimura; Sean Austin O Lim; Jose de Jesus Aceves Buendia; Joshua A Goldberg; D James Surmeier
Journal:  Front Syst Neurosci       Date:  2016-12-16

6.  Selective remodeling of glutamatergic transmission to striatal cholinergic interneurons after dopamine depletion.

Authors:  Jose de Jesus Aceves Buendia; Lior Tiroshi; Wei-Hua Chiu; Joshua A Goldberg
Journal:  Eur J Neurosci       Date:  2017-10-06       Impact factor: 3.386

7.  Ultrasonography of the Vagus Nerve in the Diagnosis of Parkinson's Disease.

Authors:  Ovidijus Laucius; Renata Balnytė; Kęstutis Petrikonis; Vaidas Matijošaitis; Neringa Jucevičiūtė; Tadas Vanagas; Vytautas Danielius
Journal:  Parkinsons Dis       Date:  2020-03-31

8.  Cav2.3 channels contribute to dopaminergic neuron loss in a model of Parkinson's disease.

Authors:  Julia Benkert; Simon Hess; Shoumik Roy; Dayne Beccano-Kelly; Nicole Wiederspohn; Johanna Duda; Carsten Simons; Komal Patil; Aisylu Gaifullina; Nadja Mannal; Elena Dragicevic; Desirée Spaich; Sonja Müller; Julia Nemeth; Helene Hollmann; Nora Deuter; Yassine Mousba; Christian Kubisch; Christina Poetschke; Joerg Striessnig; Olaf Pongs; Toni Schneider; Richard Wade-Martins; Sandip Patel; Rosanna Parlato; Tobias Frank; Peter Kloppenburg; Birgit Liss
Journal:  Nat Commun       Date:  2019-11-08       Impact factor: 14.919

Review 9.  Efficacy of Sulforaphane in Neurodegenerative Diseases.

Authors:  Giovanni Schepici; Placido Bramanti; Emanuela Mazzon
Journal:  Int J Mol Sci       Date:  2020-11-16       Impact factor: 5.923

Review 10.  Calcium, Bioenergetics, and Parkinson's Disease.

Authors:  Enrico Zampese; D James Surmeier
Journal:  Cells       Date:  2020-09-08       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.